Implementation of a Hospital in the Home model for delivery of long-acting injectable antiretroviral therapy to people living with HIV: development, integration and early experience

Key Points

• Delivery of long-acting injectable cabotegravir and rilpivirine in a home setting is feasible and safe.
• Patients showed high acceptance of the Hospital in the Home model during early implementation.
• The decentralized model could significantly improve access to HIV treatment in Australia.
• Further exploration of broad adoption is warranted for long-term patient benefits.

Abstract